SPIRIT

The MedStar Health Musculoskeletal Research and Innovation Center one of the First Research Labs in the Country to Use KUKA QUANTEC Robotic Arm

Retrieved on: 
Thursday, November 3, 2022
Injury, Elective surgery, MedStar Union Memorial Hospital, Innovation Center station, Joint, Telehealth, Surgeon, Journal of Musculoskeletal Research, SPIRIT, Trauma, Industry, Research, Leadership, Doctor of Philosophy, Technology, Health, MD, Physician, Patient, Master of Science, KUKA, MedSTAR, Integrity, Environment, MedStar Health, Patient safety, Naval Submarine Medical Research Laboratory, Hospital, Respect, Ligament, Multimedia, University, Communication, Medical device, Medicine, Robotics

BALTIMORE, Nov. 3, 2022 /PRNewswire/ -- MedStar Health has acquired a state-of-the-art KUKA KR QUANTEC robotic arm to support cutting-edge research on joint movement. Most commonly used in the automotive industry, the KUKA device will enable MedStar Health researchers to more precisely test orthopedic implants and other novel therapies to treat joint injuries.

Key Points: 
  • BALTIMORE, Nov. 3, 2022 /PRNewswire/ -- MedStar Health has acquired a state-of-the-art KUKA KR QUANTEC robotic arm to support cutting-edge research on joint movement.
  • The use of robots in healthcare has expanded significantly over the past few years, primarily with robotic-assisted surgery.
  • However, MedStar Health is one of a handful of healthcare systems to use the KUKA robotic arm in pursuit of biomechanical research.
  • In orthopedic research, scientists typically rely on custom-built machines to simulate joint movement that require lengthy setup time between experiments.

Project 10 Appoints Brandon Davis as Chief Operating Officer

Retrieved on: 
Monday, October 17, 2022
Well, CBC, TMN, SPIRIT, Vernon Wells, Growth, Broadway Video, THE, TOM, COO, Golden Globe Awards, Business, Critics' Choice Television Award for Best Comedy Series, Lionsgate, Investment, Wine, Canada, Partnership, MIPCOM, CEO, Family, SNOW, Amazon Prime Video, Association, Television, CTV, Amazon, CBC Television, Movie Central, Paramount, KIDS, HALL, Lorne Michaels, HBO (Canadian TV channel), Management, Film

As COO, Davis will support Project 10 President Ben Murray, as well as the company's development team under Shonna Foster and business affairs led by Shelby Bronstine.

Key Points: 
  • As COO, Davis will support Project 10 President Ben Murray, as well as the company's development team under Shonna Foster and business affairs led by Shelby Bronstine.
  • "Brandon's extensive business experience and unique perspective will guide Project 10 as we aspire to become a globally recognized comedy producer."
  • "Project 10 has an incredibly bright future ahead, so I'm excited to assume this official position with the company after several years of strategic advisement," said Davis.
  • The principal executives for Project 10 Productions Inc. are Chief Executive Officer Andrew Barnsley, an Executive Producer on CBC/PopTV's SCHITT'S CREEK, which won a record-setting nine EMMY Awards including Best Comedy Series in 2020; Chief Operating Officer Brandon Davis; and President Ben Murray.

Spirit Airlines Announces ISS and Glass Lewis Recommendations that Stockholders Vote FOR the Proposed Merger with JetBlue

Retrieved on: 
Thursday, October 6, 2022
Transportation, Air, Transport, Travel, Report, SPIRIT, Securities Exchange Act of 1934, ISS, NASDAQ, Securities Act of 1933, Reading, CEO, JetBlue, BY, Travel, Failure, Communication, THE, NYSE, Human, Private Securities Litigation Reform Act, Industry, Behavior, Special, Shareholder, Growth, JBLU, Glass, Annual report, Airline, Eastern Time Zone, Institutional Shareholder Services, U.S. Securities and Exchange Commission, Disease, Sale, SEC, Spirit Airlines, Coronavirus, Â, Forward-looking statement, Public health, Holding company, Security (finance), Spirit

Spirit Airlines, Inc. (Spirit or the Company) (NYSE: SAVE) today announced that leading independent proxy advisory firms Institutional Shareholder Services (ISS) and Glass, Lewis & Co. (Glass Lewis) have recommended that Spirit stockholders vote FOR the merger agreement with JetBlue Airways Corporation (JetBlue) (NASDAQ: JBLU).

Key Points: 
  • Spirit Airlines, Inc. (Spirit or the Company) (NYSE: SAVE) today announced that leading independent proxy advisory firms Institutional Shareholder Services (ISS) and Glass, Lewis & Co. (Glass Lewis) have recommended that Spirit stockholders vote FOR the merger agreement with JetBlue Airways Corporation (JetBlue) (NASDAQ: JBLU).
  • Glass Lewis acknowledged stockholders as of the record date of the meeting stand to receive an accelerated payment from JetBlue in the amount of $2.50 per Spirit share.
  • Spirit has scheduled the Special Meeting of Stockholders (the Special Meeting) to approve the proposed merger with JetBlue for Wednesday, October 19, 2022, at 9:00 a.m., Eastern Time.
  • This communication may be deemed to be solicitation material in respect of the proposed merger between JetBlue and Spirit.

EQS-News: Biohacks (Schweiz) AG: 'SPIRIT' wins over German universities

Retrieved on: 
Wednesday, October 5, 2022
SPAR (retailer), SPIRIT, Biohackers, Caffeine, Energy, Billa, Forest, Seabed warfare, Edeka, Spirit, Drink, Philosophy, Student, Biodiversity, Taurine, Budni, University, JET, Tegut, Environmental protection, Coffee, Renewable energy, DACH, Riley Voelkel, PKN Orlen

The bags, with SPIRIT branding on the sides and each containing a sample can, are being handed out directly to the students.

Key Points: 
  • The bags, with SPIRIT branding on the sides and each containing a sample can, are being handed out directly to the students.
  • As a next step, "SPIRIT" is aiming at the listing at student canteens halls and cafeterias via the student unions.
  • Following successful listing, the campaign will also include marketing measures such as billboard advertising, direct promotion and guerrilla marketing.
  • With its SPIRITs, Biohacks is offering the ideal range for this: The basic ingredients of the drinks come from sustainable cultivation.

Neurotech Company Neuvana Part of a Major National Research Grant Awarded to the University of Notre Dame

Retrieved on: 
Tuesday, October 4, 2022
Vagus nerve stimulation, Emotion, Intervention, Plasma protein binding, Technology, Psychology, Research, Life, SPIRIT, PALM, CEO, MD, Suicide Behaviors Questionnaire-Revised, Self-harm, Philosophy, LLC, Notre Dame, National, Science, Vagus nerve, Program, Boca Raton Regional Hospital, Suicide, Risk, University, Xen, GLOBE, Management, Neuroscience

WEST PALM BEACH, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Neuvana , a South Florida-based neurotech company, is proud to announce its flagship product, Xen, will be part of a $4 million research grant awarded to the University of Notre Dame , the recipient of the Transformative Research Award from the National Institutes of Health .

Key Points: 
  • WEST PALM BEACH, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Neuvana , a South Florida-based neurotech company, is proud to announce its flagship product, Xen, will be part of a $4 million research grant awarded to the University of Notre Dame , the recipient of the Transformative Research Award from the National Institutes of Health .
  • Xen is the first-of-its-kind product available to consumers that targets the vagus nerve through electrical stimulation to help regulate the bodys nervous system.
  • For more information about the product, visit www.neuvanalife.com and to learn more about Notre Dames SPIRIT program, visit https://preventsuicide.nd.edu .
  • Neuvana, LLC is a South Florida-based company at the intersection of wellness andtechnology, with a focus on Neuroscience.

MedStar Health Awarded Additional $2 Million Grant to Expand Research on National Telehealth Access, Safety, and Health Equity

Retrieved on: 
Tuesday, September 27, 2022
Adult, Integrity, Safety, MedSTAR, AHRQ, Disability, Risk, MD, Conditional sentence, MedStar Health, Intermountain Healthcare, Telehealth, Connected, Stanford University School of Medicine, United States Department of Health and Human Services, Health equity, Patient, Agency, Office of Inspector General, U.S. Department of Health and Human Services, Physician, Human factors and ergonomics, Technology, Doctor of Philosophy, Respect, Patient safety, List of Medknow Publications academic journals, Agency for Healthcare Research and Quality, Hospital, Multimedia, University, Stanford University Medical Center, Equity, Microsoft Research, SPIRIT, Pharmaceutical industry, Medical device, Health insurance, Medicine, Risk management, Medicare, Research, Medicaid, Health

 COLUMBIA, Md., Sept. 27, 2022 /PRNewswire/ -- MedStar Health has received a nearly $2 million grant from the Agency for Healthcare Research and Quality (AHRQ) to expand its research collaboration with Stanford Medicine and Intermountain Healthcare focused on telehealth access, safety, and equity. The grant will allow researchers to establish a patient safety learning laboratory over a four-year funding period to apply a cross-disciplinary, human factors and systems engineering approach to connected care enhancements, especially among patients with chronic conditions and other vulnerable populations.

Key Points: 
  • MedStar Health awarded new $2M grant from AHRQ to expand research focused on telehealth access, safety, and equity.
  • The study found the unprecedented availability of telehealth during the pandemic did not lead to an increase in unnecessary primary care sessions.
  • Through the new grant, the team will continue work under the name Connected CARECare Access, Research, Equity& Safety Consortium and expand beyond their initial focus on primary care.
  • This AHRQ grant is a prestigious U.S. Department of Health and Human Services' R18 award and is the second such effort led by MedStar Health.

Spirit Blockchain Capital Inc. Announces setting up its first Avalanche Validator Node

Retrieved on: 
Tuesday, September 6, 2022
Blockchain Capital, Ethereum, EVM, CSE, Forensic science, Spirit, Solution, SPIRIT, Decentralized finance, Sale, AML, Share (finance), Blockchain, Person, Judgement, POS, Treasury, Canadian Securities Exchange, GLOBE, Compliance, AVAX, Company, News, Common Criteria Evaluation and Validation Scheme, SEDAR, Ecosystem, Industry, Growth, Environment, Avalanche, Cryptocurrency, Security (finance)

Avalanche is one of the worlds most decentralized high-performance blockchains and continues to experience rapid growth.

Key Points: 
  • Avalanche is one of the worlds most decentralized high-performance blockchains and continues to experience rapid growth.
  • The Avalanche network is a Proof-of-Stake (PoS) smart contract platform that is focused on scalability and offers fast transaction finality.
  • By becoming an active validator of the Avalanche network, SPIRIT plans to be a long-term supporter of the blockchain, contribute to decentralization and participate in protocol governance.
  • Furthermore, 3rd parties are able to delegate their AVAX tokens to the SPIRIT validator node, for which SPIRIT earns a commission.

Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis

Retrieved on: 
Saturday, August 6, 2022
Linda, FDA, Woman, Hospital, Dysmenorrhea, UCSF, Endometriosis, NYSE, Internal medicine, GLOBE, University of California, San Francisco, NEW, Senior, Norethisterone, Roivant Sciences, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Pfizer, PFE, Pain, Patient, SPIRIT, Uterine fibroid, Safety, Rusyns, Webcast, Physician, University, Conditional sentence, Chair, Food, Health, Disease, Pharmaceutical industry, Dentistry, Lancet

MYFEMBREE offers an effective, once-daily treatment option for the management of moderate to severe pain associated with endometriosis, with a treatment duration of up to 24 months.

Key Points: 
  • MYFEMBREE offers an effective, once-daily treatment option for the management of moderate to severe pain associated with endometriosis, with a treatment duration of up to 24 months.
  • MYFEMBREE is available immediately to patients with moderate to severe pain associated with endometriosis with a prescription from their healthcare provider.
  • Myovant and Pfizer also are committed to supporting women in the U.S. who are prescribed MYFEMBREE throughout their treatment journeys.
  • Food and Drug Administration for the management of moderate to severe pain associated with endometriosis, with a treatment duration of up to 24 months.

ISS, Leading Proxy Advisor, Formally Recommends Spirit Shareholders Vote Against Frontier Transaction

Retrieved on: 
Friday, July 15, 2022
Transportation, Air, Transport, Travel, SEC, Public health, Shearman, Money transmitter, Securities Exchange Act of 1934, Disease, Institutional Shareholder Services, U.S. Securities and Exchange Commission, Goldman Sachs, Fortification, SPIRIT, LLP, Private Securities Litigation Reform Act, Forward-looking statement, BLUE, JBLU, Travel, Securities Act of 1933, NASDAQ, Behavior, ALL, Coronavirus, Letter, City, Shearman & Sterling, Annual report, ISS, Management, Security (finance), Auction, JetBlue, Spirit, Frontier

JetBlue (NASDAQ: JBLU) issued the following statement regarding the revised recommendation issued by Institutional Shareholder Services (ISS), a leading proxy advisory firm:

Key Points: 
  • JetBlue (NASDAQ: JBLU) issued the following statement regarding the revised recommendation issued by Institutional Shareholder Services (ISS), a leading proxy advisory firm:
    We are pleased that ISS chose to formally update its recommendation to Spirit shareholders to vote AGAINST the Frontier transaction.
  • ISS concluded:
    The provisions of the JetBlue proposal ... appear more favorable for Spirit shareholders than the best-and-final merger terms from Frontier.
  • Shareholders are therefore recommended to vote AGAINST the proposed merger with Frontier.
  • We remain confident that Spirit shareholders continue to overwhelmingly recognize the clear superiority of our proposal, and strongly encourage them to vote AGAINST the Frontier transaction.

JetBlue Comments on Spirit’s Adjournment of Special Meeting

Retrieved on: 
Wednesday, July 13, 2022
Communications, Air, Transport, Transportation, Travel, Public Relations, Investor Relations, ALL, Public health, Disease, Fortification, Shearman, SEC, Letter, LLP, BLUE, Annual report, SPIRIT, Special, U.S. Securities and Exchange Commission, Securities Act of 1933, Travel, Securities Exchange Act of 1934, Goldman Sachs, Money transmitter, Private Securities Litigation Reform Act, City, Shearman & Sterling, Forward-looking statement, JBLU, Ouija, NYSE, Behavior, Board of directors, Frontier, NASDAQ, Coronavirus, Management, Airline, Security (finance), Auction, JetBlue, Spirit

Despite this and Spirits shareholders repeated and now increasingly public acknowledgements that JetBlues latest proposal is clearly superior in every respect, by moving the Special Meeting again, the Spirit Board is delaying the ability of Spirit shareholders to receive JetBlues superior terms.

Key Points: 
  • Despite this and Spirits shareholders repeated and now increasingly public acknowledgements that JetBlues latest proposal is clearly superior in every respect, by moving the Special Meeting again, the Spirit Board is delaying the ability of Spirit shareholders to receive JetBlues superior terms.
  • Goldman Sachs & Co. LLC is serving as JetBlues financial advisor and Shearman & Sterling LLP is serving as JetBlues legal advisor.
  • JetBlue is New York's Hometown Airline, and a leading carrier in Boston, Fort Lauderdale-Hollywood, Los Angeles, Orlando, and San Juan.
  • JetBlue carries customers to more than 100 cities throughout the United States, Latin America, Caribbean, Canada, and United Kingdom.